Chi‐Jen Chu

1.9k total citations
58 papers, 1.0k citations indexed

About

Chi‐Jen Chu is a scholar working on Hepatology, Epidemiology and Biochemistry. According to data from OpenAlex, Chi‐Jen Chu has authored 58 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Hepatology, 41 papers in Epidemiology and 6 papers in Biochemistry. Recurrent topics in Chi‐Jen Chu's work include Liver Disease Diagnosis and Treatment (39 papers), Hepatitis C virus research (29 papers) and Liver Disease and Transplantation (21 papers). Chi‐Jen Chu is often cited by papers focused on Liver Disease Diagnosis and Treatment (39 papers), Hepatitis C virus research (29 papers) and Liver Disease and Transplantation (21 papers). Chi‐Jen Chu collaborates with scholars based in Taiwan, United States and Vietnam. Chi‐Jen Chu's co-authors include Shou‐Dong Lee, Han‐Chieh Lin, Yi‐Hsiang Huang, Che‐Chang Chan, Fa‐Yauh Lee, Munira Hussain, Anna S. Lok, Erwin Sablon, Ming-Chih Hou and Chia-Fen Tsai and has published in prestigious journals such as Gastroenterology, Hepatology and Scientific Reports.

In The Last Decade

Chi‐Jen Chu

56 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chi‐Jen Chu Taiwan 18 773 764 178 73 71 58 1.0k
Paolo Borro Italy 17 740 1.0× 805 1.1× 386 2.2× 67 0.9× 44 0.6× 42 1.2k
Vivek A. Saraswat India 15 586 0.8× 535 0.7× 304 1.7× 36 0.5× 45 0.6× 26 906
Thomas Sersté Belgium 16 883 1.1× 823 1.1× 424 2.4× 30 0.4× 88 1.2× 37 1.1k
Vincents J. Dindzans United States 14 595 0.8× 480 0.6× 302 1.7× 21 0.3× 62 0.9× 31 870
Osman Özdoğan Türkiye 16 504 0.7× 803 1.1× 235 1.3× 110 1.5× 12 0.2× 66 1.1k
Jean‐François Cadranel France 11 808 1.0× 913 1.2× 160 0.9× 21 0.3× 29 0.4× 30 1.1k
Ghassan Riachi France 13 332 0.4× 297 0.4× 100 0.6× 33 0.5× 22 0.3× 36 554
Andrew Austin United Kingdom 16 706 0.9× 844 1.1× 359 2.0× 14 0.2× 50 0.7× 26 1.1k
Maria Kalafateli Greece 17 410 0.5× 414 0.5× 179 1.0× 220 3.0× 23 0.3× 49 943

Countries citing papers authored by Chi‐Jen Chu

Since Specialization
Citations

This map shows the geographic impact of Chi‐Jen Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi‐Jen Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi‐Jen Chu more than expected).

Fields of papers citing papers by Chi‐Jen Chu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chi‐Jen Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi‐Jen Chu. The network helps show where Chi‐Jen Chu may publish in the future.

Co-authorship network of co-authors of Chi‐Jen Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Chi‐Jen Chu. A scholar is included among the top collaborators of Chi‐Jen Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chi‐Jen Chu. Chi‐Jen Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yen, Chia‐Jui, et al.. (2025). Circulating tumor DNA methylation markers for the early diagnosis of hepatocellular carcinoma. Clinical and Experimental Medicine. 25(1). 83–83.
2.
Tan, Elise Chia‐Hui, Pei‐Chang Lee, Chi‐Jen Chu, et al.. (2024). Conventional and machine learning-based risk scores for patients with early-stage hepatocellular carcinoma. Clinical and Molecular Hepatology. 30(3). 406–420. 10 indexed citations
3.
Chu, Chi‐Jen, Pei‐Chang Lee, Teh‐Ia Huo, et al.. (2022). The outcomes and prognostic factors of patients with hepatocellular carcinoma and normal serum alpha fetoprotein levels. Journal of the Formosan Medical Association. 122(7). 593–602. 8 indexed citations
4.
Tsai, Chia-Fen, Pei-Chi Tu, Yen‐Po Wang, et al.. (2019). Altered cognitive control network is related to psychometric and biochemical profiles in covert hepatic encephalopathy. Scientific Reports. 9(1). 6580–6580. 11 indexed citations
5.
Chu, Chi‐Jen, et al.. (2019). Successful treatment with sofosbuvir and daclatasvir plus ribavirin in acute hepatitis C-infected patient with hepatic decompensation. Journal of the Chinese Medical Association. 82(7). 595–598. 3 indexed citations
6.
Chen, Chi-Yi, Chien‐Wei Su, Po‐Yueh Chen, et al.. (2019). Direct-acting antivirals for patients with chronic hepatitis C and hepatocellular carcinoma in Taiwan. Journal of Microbiology Immunology and Infection. 54(3). 385–395. 13 indexed citations
7.
Kao, Jia‐Horng, Rong‐Nan Chien, Ting‐Tsung Chang, et al.. (2016). A phase 3b study of sofosbuvir plus ribavirin in Taiwanese patients with chronic genotype 2 hepatitis C virus infection. Liver International. 36(8). 1101–1107. 22 indexed citations
8.
Chuang, Wan‐Long, Rong‐Nan Chien, Cheng‐Yuan Peng, et al.. (2016). Ledipasvir/sofosbuvir fixed‐dose combination tablet in Taiwanese patients with chronic genotype 1 hepatitis C virus. Journal of Gastroenterology and Hepatology. 31(7). 1323–1329. 22 indexed citations
9.
Tsai, Chia-Fen, Mu‐Hong Chen, Yen‐Po Wang, et al.. (2016). Proton Pump Inhibitors Increase Risk for Hepatic Encephalopathy in Patients With Cirrhosis in A Population Study. Gastroenterology. 152(1). 134–141. 124 indexed citations
10.
Yang, Ying‐Ying, Ming‐Wei Lin, Ming-Chih Hou, et al.. (2014). Benzodiazepine-Associated Hepatic Encephalopathy Significantly Increased Healthcare Utilization and Medical Costs of Chinese Cirrhotic Patients: 7-Year Experience. Digestive Diseases and Sciences. 59(7). 1603–1616. 12 indexed citations
11.
Hung, Tsung‐Hsing, et al.. (2012). Is transarterial chemoembolization beneficial for patients with diffuse infiltrative hepatocellular carcinoma?. Hepatology International. 7(2). 676–682. 8 indexed citations
12.
Tsai, Chia-Fen, Chia‐Jen Liu, Tzeng‐Ji Chen, et al.. (2012). Increased incidence of orthopedic fractures in cirrhotic patients: A nationwide population-based study. Journal of Hepatology. 58(4). 706–714. 34 indexed citations
13.
Lee, I‐Cheng, Yi‐Hsiang Huang, Che‐Chang Chan, et al.. (2011). Impact of body mass index and viral load on liver histology in hepatitis B e antigen-negative chronic hepatitis B. Clinical Nutrition. 30(5). 647–652. 21 indexed citations
14.
Lee, I‐Cheng, Yi‐Hsiang Huang, Che‐Chang Chan, et al.. (2010). Correlation between clinical indication for treatment and liver histology in HBeAg-negative chronic hepatitis B: a novel role of α-fetoprotein. Liver International. 30(8). 1161–1168. 11 indexed citations
15.
Huang, Kuo-Cherh, et al.. (2010). Influencing Factors of Healthcare-Seeking Behaviors in Taiwanese Patients With Hepatitis C. Gastroenterology Nursing. 33(6). 414–420. 3 indexed citations
16.
Chu, Chi‐Jen & Shou‐Dong Lee. (2008). Hepatitis B virus/hepatitis C virus coinfection: Epidemiology, clinical features, viral interactions and treatment. Journal of Gastroenterology and Hepatology. 23(4). 512–520. 157 indexed citations
17.
Hsia, Cheng‐Yuan, Chi‐Jen Chu, Yi‐Hsiang Huang, et al.. (2007). The predictive ability of serum α‐fetoprotein for hepatocellular carcinoma is linked with the characteristics of the target population at surveillance. Journal of Surgical Oncology. 95(8). 645–651. 10 indexed citations
18.
Wang, Sun‐Sang, Fa‐Yauh Lee, Cho‐Yu Chan, et al.. (2007). Simvastatin for rats with thioacetamide‐induced liver failure and encephalopathy. Journal of Gastroenterology and Hepatology. 23(7pt2). e236–42. 8 indexed citations
19.
Chan, Che‐Chang, FA‐YAUH LEE, Full‐Young Chang, et al.. (2001). Endothelin–1 Induces Vasoconstriction on Portal–Systemic Collaterals of Portal Hypertensive Rats. Hepatology. 33(4). 816–820. 34 indexed citations
20.
Li, Chung‐Pin, Shinn‐Jang Hwang, Fa‐Yauh Lee, et al.. (2000). Evaluation of Gallbladder Motility in Patients with Liver Cirrhosis. Digestive Diseases and Sciences. 45(6). 1109–1114. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026